Get the Stockscreener App
49.64
2.54%
1.23
Pre-market:
49.86
0.22
+0.44%
Hims Hers Health Inc stock is traded at $49.64, with a volume of 34.88M.
It is up +2.54% in the last 24 hours and down -4.43% over the past month.
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.
See More
Previous Close:
$48.41
Open:
$49.12
24h Volume:
34.88M
Relative Volume:
0.99
Market Cap:
$10.80B
Revenue:
$1.78B
Net Income/Loss:
$164.40M
P/E Ratio:
71.94
EPS:
0.69
Net Cash Flow:
$236.51M
1W Performance:
+17.21%
1M Performance:
-4.43%
6M Performance:
+38.08%
1Y Performance:
+263.66%
1-Day Range:
$49.09
$51.59
1-Week Range:
$40.78
$51.59
52-Week Range:
$13.70
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Name
Hims Hers Health Inc
Sector
Industry
Phone
415-851-0195
Address
2269 CHESTNUT ST, SAN FRANCISCO
Compare HIMS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
49.64 | 10.94B | 1.78B | 164.40M | 236.51M | 0.69 |
|
PG
Procter Gamble Co
|
159.01 | 374.83B | 84.28B | 16.07B | 14.05B | 6.51 |
|
UL
Unilever Plc Adr
|
64.00 | 157.68B | 64.99B | 6.71B | 6.53B | 2.4495 |
|
CL
Colgate Palmolive Co
|
84.19 | 68.80B | 20.00B | 3.05B | 3.37B | 3.56 |
|
KMB
Kimberly Clark Corp
|
129.78 | 43.09B | 18.88B | 2.38B | 2.10B | 7.26 |
|
KVUE
Kenvue Inc
|
18.43 | 35.73B | 15.14B | 1.42B | 1.63B | 0.74 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-23-25 | Downgrade | Needham | Buy → Hold |
| Jun-04-25 | Reiterated | Needham | Buy |
| Apr-29-25 | Downgrade | TD Cowen | Buy → Hold |
| Feb-18-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-10-25 | Downgrade | Citigroup | Neutral → Sell |
| Jan-07-25 | Initiated | BTIG Research | Buy |
| Dec-17-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-22-24 | Initiated | Needham | Buy |
| Aug-09-24 | Downgrade | Imperial Capital | Outperform → In-line |
| May-22-24 | Downgrade | Citigroup | Buy → Neutral |
| Apr-16-24 | Downgrade | Jefferies | Buy → Hold |
| Apr-10-24 | Initiated | Canaccord Genuity | Buy |
| Feb-28-24 | Upgrade | Imperial Capital | In-line → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | Imperial Capital | In-line |
| Jul-28-23 | Initiated | TD Cowen | Outperform |
| Apr-11-23 | Initiated | Robert W. Baird | Neutral |
| Feb-09-23 | Upgrade | Jefferies | Hold → Buy |
| Nov-08-22 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-08-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Oct-17-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-07-22 | Initiated | Truist | Hold |
| Jul-15-22 | Initiated | SVB Leerink | Underperform |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-10-22 | Initiated | Deutsche Bank | Hold |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Nov-11-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jul-06-21 | Initiated | BofA Securities | Neutral |
| May-20-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-21-21 | Initiated | Truist | Hold |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Mar-02-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Initiated | Citigroup | Neutral |
| Feb-12-21 | Initiated | Piper Sandler | Neutral |
| Feb-08-21 | Initiated | Tigress Financial | Buy |
View All
Hims Hers Health Inc Stock (HIMS) Latest News
Hims & Hers Expanding Partnerships to Build a Global Health Ecosystem - Yahoo Finance
Ohio to tighten oversight of weight-loss copies by limiting inventory - Reuters
Hers Health Inc. is moving todayNew Guidance & Accurate Buy Signal Notifications - Newser
Hims & Hers Health Stock Surges Amid Expansion - TipRanks
Hims & Hers Health signs 15-year lease for Ohio facility with $5.98 million annual rent - Investing.com Canada
Hims & Hers Health: Pioneering the Future of Digital Healthcare Amid Secular Megatrends - AInvest
Hims & Hers Health: At The Intersection Of Secular Megatrends (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health Expands with New Ohio Facility - TipRanks
Hers Health Inc. in sector analysisInsider Selling & Weekly Top Gainers Trade List - Newser
Hers Health Inc. stock trendline breakdown2025 Trading Recap & Low Risk High Reward Ideas - Newser
Hims & Hers (HIMS) Steals Spotlight as Court Junks Eli Lilly Lawsuit vs 4 Telehealth Firms - Insider Monkey
Hims & Hers Health: A Disruptive Force in Personalized Digital Healthcare and Its Implications for Long-Term Growth - AInvest
Exclusive: Remedy Meds to acquire Thirty Madison - Axios
Why Hims & Hers Health (HIMS) Stock Is Up Today - Yahoo Finance
Sustainable weight loss with Hims & Hers - fox10tv.com
Experts discuss the impact of limited insurance coverage on obesity treatment access - KOKH
BofA Securities maintains Underperform rating on Hims and Hers stock By Investing.com - Investing.com Australia
BofA Securities maintains Underperform rating on Hims and Hers stock - Investing.com
4 Top Stocks to Buy in September - The Motley Fool
HIMS Stock Climbs 7% after Eli Lilly’s Knockoff Case Falls Flat - TipRanks
Navigating the Storm: Hims & Hers' Legal Resilience in the Telehealth and Compounded Drug Sector - AInvest
Eli Lillys 036 Gains Overshadowed by 3075 Volume Drop as Court Dismisses Lawsuit Stock Ranks 33rd in Market Activity Amid Hims Surge - AInvest
Strategic Capital Moves in Disruptive Consumer & Mobility Sectors: Lyft, Hims & Hers, and Constellation Brands - AInvest
Noteworthy Wednesday Option Activity: HIMS, UNH, SMMT - Nasdaq
Lyft convertible notes, Hims & Hers surges, Constellation Brands - Yahoo Finance
Hims & Hers Health Stock (HIMS) Opinions on Telehealth Innovation and Recent Setbacks - Quiver Quantitative
Hims & Hers gains after court rejects Eli Lilly’s case against Willow - Yahoo Finance
Hims & Hers Health Set to Meet Revenue Projections Amid Growing Confidence - StocksToTrade
Hims & Hers Sees Revenue Growth Amid Deutsche Bank’s Optimistic Outlook - timothysykes.com
Hers Health Inc.Weekly Market Report & Community Consensus Picks - Newser
Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock - Yahoo Finance
HIMS' Personalized Wellness Platform Expands Preventive Care Access - sharewise.com
Hers Health Inc. holdersEarnings Overview Report & Daily Stock Trend Reports - Newser
Hers Health Inc. reversing from oversold territoryLayoff News & Accurate Buy Signal Notifications - Newser
Hims & Hers Health: Still Undervalued (NYSE:HIMS) - Seeking Alpha
Hers Health Inc. stock trend forecastRisk Management & Reliable Volume Spike Trade Alerts - Newser
Hers Health Inc. bounce back from current support2025 Price Targets & AI Enhanced Trading Signals - Newser
Insider Moves: Datadog, Hims & Hers, Opendoor, Texas Instruments, Vertiv - TipRanks
Truist Cuts Hims & Hers Health, Inc. (HIMS) Price Target, Cites Mixed Revenue Outlook - MSN
Hers Health Inc.’s reversalGap Down & Stock Timing and Entry Methods - Newser
Hims & Hers: The Dominant Health Platform Of The Future (NYSE:HIMS) - Seeking Alpha
Real time social sentiment graph for HIMSNew Guidance & Safe Entry Trade Reports - Newser
Hers Health Inc. stock entering bullish territoryTrade Exit Report & Growth Focused Entry Reports - Newser
Hims & Hers Climbs to 102nd in Market Activity With $790M Volume as Insider Sales and Mixed Earnings Spark Doubts - AInvest
Hims & Hers Health Insider Selling: Signal of Distrust or Strategic Rebalancing? - AInvest
Hers Health Inc. in the next 30 daysPortfolio Growth Summary & Weekly Top Gainers Alerts - Newser
HIMS vs. AMWL: Which Stock Has the Stronger Global Growth Strategy? - The Globe and Mail
Hims Hers Health Inc Stock (HIMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.01%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):